117 related articles for article (PubMed ID: 16357523)
1. Production and post-surgical modification of VEGF, tPA and PAI-1 in patients with glioma.
Salmaggi A; Croci D; Prina P; Cajola L; Pollo B; Marras CE; Ciusani E; Silvani A; Boiardi A; Sciacca FL
Cancer Biol Ther; 2006 Feb; 5(2):204-9. PubMed ID: 16357523
[TBL] [Abstract][Full Text] [Related]
2. Genetic and plasma markers of venous thromboembolism in patients with high grade glioma.
Sciacca FL; Ciusani E; Silvani A; Corsini E; Frigerio S; Pogliani S; Parati E; Croci D; Boiardi A; Salmaggi A
Clin Cancer Res; 2004 Feb; 10(4):1312-7. PubMed ID: 14977830
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activators and inhibitors in gliomas: an immunohistochemical study.
Caccamo DV; Keohane ME; McKeever PE
Mod Pathol; 1994 Jan; 7(1):99-104. PubMed ID: 8159659
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein(a), tissue plasminogen activator and plasminogen activator inhibitor 1 levels in hyperlipidaemic patients in Kuwait.
Akanji AO; Abdullah A; Tahzeeb S
Eur J Clin Invest; 1997 May; 27(5):380-6. PubMed ID: 9179544
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor-1 increases the expression of VEGF in human glioma cells.
Hjortland GO; Lillehammer T; Somme S; Wang J; Halvorsen T; Juell S; Hirschberg H; Fodstad Ø; Engebraaten O
Exp Cell Res; 2004 Mar; 294(1):130-9. PubMed ID: 14980508
[TBL] [Abstract][Full Text] [Related]
6. Expression of the proteolytic factors, tPA and uPA, PAI-1 and VEGF during malignant glioma progression.
Sandström M; Johansson M; Sandström J; Bergenheim AT; Henriksson R
Int J Dev Neurosci; 1999; 17(5-6):473-81. PubMed ID: 10571409
[TBL] [Abstract][Full Text] [Related]
7. Tissue-type plasminogen activator and its inhibitor in rat aorta. Effect of endotoxin.
Padró T; Quax PH; van den Hoogen CM; Roholl P; Verheijen JH; Emeis JJ
Arterioscler Thromb; 1994 Sep; 14(9):1459-65. PubMed ID: 8068608
[TBL] [Abstract][Full Text] [Related]
8. Expression of the plasminogen activator system in the human vascular wall.
Salame MY; Samani NJ; Masood I; deBono DP
Atherosclerosis; 2000 Sep; 152(1):19-28. PubMed ID: 10996335
[TBL] [Abstract][Full Text] [Related]
9. Clinical importance of angiogenic cytokines, fibrinolytic activity and effusion size in parapneumonic effusions.
Chung CL; Hsiao SH; Hsiao G; Sheu JR; Chen WL; Chang SC
PLoS One; 2013; 8(1):e53169. PubMed ID: 23308155
[TBL] [Abstract][Full Text] [Related]
10. Modulation of tissue-type plasminogen activator expression by platelet activating factor in human glioma cells.
Akai T; Niiya K; Sakuragawa N; Iizuka H; Endo S
J Neurooncol; 2002 Sep; 59(3):193-8. PubMed ID: 12241114
[TBL] [Abstract][Full Text] [Related]
11. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential.
Lockwood CJ; Krikun G; Aigner S; Schatz F
J Clin Endocrinol Metab; 1996 Jan; 81(1):107-12. PubMed ID: 8550736
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of VEGF and components of the plasminogen activator system in endometrial cancer.
Abbink K; Zusterzeel PLM; Geurts-Moespot A; van der Steen R; Span PN; Sweep FCGJ
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1725-1735. PubMed ID: 32394054
[TBL] [Abstract][Full Text] [Related]
13. Prolactin regulation of tissue type plasminogen activator and plasminogen activator inhibitor type-I gene expression in eCG-primed rat granulosa cells in culture.
Liu YX; Peng XR; Liu HZ; Chen YJ; Ny T
Biol Reprod; 1998 Aug; 59(2):409-16. PubMed ID: 9687315
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells.
van Leeuwen RT; Kol A; Andreotti F; Kluft C; Maseri A; Sperti G
Circulation; 1994 Jul; 90(1):362-8. PubMed ID: 8026020
[TBL] [Abstract][Full Text] [Related]
15. Acute psychological stress decreases plasma tissue plasminogen activator (tPA) and tissue plasminogen activator/plasminogen activator inhibitor-1 (tPA/PAI-1) complexes in cardiac patients.
Hevey D; McGee HM; Fitzgerald D; Horgan JH
Eur J Appl Physiol; 2000 Nov; 83(4 -5):344-8. PubMed ID: 11138573
[TBL] [Abstract][Full Text] [Related]
16. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
Wiman B; Andersson T; Hallqvist J; Reuterwall C; Ahlbom A; deFaire U
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
[TBL] [Abstract][Full Text] [Related]
17. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
Lindgren A; Lindoff C; Norrving B; Astedt B; Johansson BB
Stroke; 1996 Jun; 27(6):1066-71. PubMed ID: 8650716
[TBL] [Abstract][Full Text] [Related]
18. Cell-free mRNA concentrations of plasminogen activator inhibitor-1 and tissue-type plasminogen activator are increased in the plasma of pregnant women with preeclampsia.
Purwosunu Y; Sekizawa A; Koide K; Farina A; Wibowo N; Wiknjosastro GH; Okazaki S; Chiba H; Okai T
Clin Chem; 2007 Mar; 53(3):399-404. PubMed ID: 17234729
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.
Watanabe R; Wada H; Miura Y; Murata Y; Watanabe Y; Sakakura M; Okugawa Y; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Shiku H; Nobori T
Clin Appl Thromb Hemost; 2001 Jul; 7(3):229-33. PubMed ID: 11441985
[TBL] [Abstract][Full Text] [Related]
20. Impact of diabetes-associated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells.
Ren S; Lee H; Hu L; Lu L; Shen GX
J Clin Endocrinol Metab; 2002 Jan; 87(1):286-91. PubMed ID: 11788661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
